Man Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$277K Buy
2024
Q1
Sell
2023
Q4
$945K Buy
2023
Q3
Sell
2023
Q2
$828K Buy
2023
Q1
Sell
2022
Q4
$947K Buy
2022
Q3
$388K Buy
2022
Q1
Sell
2021
Q4
$727K Buy
2021
Q2
Sell
2021
Q1
$512K Sell
2020
Q4
$7.21M Sell
2020
Q3
$4.21M Buy
2020
Q2
$932K Buy